HKSE · Stocky rates: Cautious

CIRRUS (2507.HK)

HK$43.94 ▼ -0.23% as of 6 Aug, 13:30
49
/ 100
Neutral

What Stocky thinks

Cautious. China SiC (2507.HK) faces misaligned incentives—controlling shareholders hold 72% while independent directors comprise only 33% of the board, creating governance friction. The company operates in high-growth silicon carbide semiconductors, but weak leadership accountability and absence of founder-CEO alignment undermine confidence in capital allocation and strategic execution during a competitive chip cycle.

Compounder Score
50/100
Business quality — profitability, growth, capital efficiency.
Leadership Alignment
45/100
Founder-led, insider ownership, capital allocation history.

What Stocky gives investors that other tools don't

Every stock is scored across six proprietary dimensions built for retail investors who want Buffett-quality analysis without a Bloomberg subscription. Here's the actual snapshot for CIRRUS:

49
VERDICT

Stocky Verdict — one score, everything

Quality + moat + leadership + valuation + sentiment fused into a single 0–100 number. When you see 49/100, you know instantly whether to dig deeper or skip.

Rated
MOAT

Moat Score — is there a real edge?

Pricing power, switching costs, network effects, and 10-year ROIC data. Same framework Morningstar charges for — free inside Stocky.

45
LEADER

Leadership Alignment — is management on your side?

Founder tenure, insider ownership, CEO pay reasonableness, long-term value creation. Six factors, one score — turns "trust the CEO" into evidence.

RISK

Vulnerability Profile — what could break?

Customer concentration, supply chain, refinancing walls, regulatory exposure. Stocky maps knowable fragilities so you're never blindsided.

Elite
TRACK

Track Record — does the system work?

Every score backtested against real S&P 500 returns. See how "Elite" (90+ Verdict) picks have performed vs the index — no black boxes.

24/7
ALERTS

Alerts + Portfolio insights

Analyst target shifts, insider buys, big moves — plus a monthly Portfolio Health Report telling you what's actually driving your returns.

CIRRUS (2507.HK) — frequently asked

Is CIRRUS (2507.HK) a good investment right now?

Stocky rates CIRRUS (2507.HK) at 49/100 — below the bar Stocky looks for. The score fuses business quality, moat width, leadership alignment, valuation and analyst signal into a single number. Cautious. China SiC (2507.HK) faces misaligned incentives—controlling shareholders hold 72% while independent directors comprise only 33% of the board, creating governance friction. The company operates in high-growth silicon carbide semico

What is 2507.HK's Stocky Verdict?

2507.HK's current Stocky Verdict is 49/100, placing it in the "Cautious" band. This composite combines a 50/100 Compounder score, 45/100 Leadership, Moat rating, and analyst signal.

Does CIRRUS have a competitive moat?

Stocky hasn't finalised a Moat Score for CIRRUS yet — the analysis draws from ROIC trends, pricing power evidence, and competitive-position filings.

Is CIRRUS's leadership aligned with shareholders?

CIRRUS scores 45/100 on Leadership Alignment. Higher = more founder involvement, higher insider ownership, sensible pay, and evidence of long-term capital allocation discipline.

What are the biggest risks to 2507.HK?

Vulnerability Profile for CIRRUS covers customer concentration, supply chain risk, refinancing walls, and regulatory exposure. Not yet finalised.

This is just the surface. See the whole picture on CIRRUS.

Sign up free and unlock the full analysis on 2507.HK — the same tools professional analysts use, personalised to your portfolio:

  • Every analyst covering 2507.HK — full list with star ratings, price targets, historical hit-rate. Not just the top 3 you see above.
  • Full Vulnerability Profile — customer concentration, refinancing walls, stress-test scenarios (-20% revenue, +200bp rates) modelled specifically for 2507.HK.
  • Bull & bear thesis — the AI-written counter-argument every retail investor forgets to read.
  • Portfolio fit check — how 2507.HK changes your sector concentration, correlation and Verdict-weighted quality.
  • Ask Stocky AI — "What are the biggest 3-year risks to 2507.HK?" · "Is 2507.HK overvalued vs its 5-year median?" · unlimited follow-ups on your portfolio.
  • Live alerts — analyst target changes, insider buys, big moves — the day they happen.
Start free · 14 days Plus, no card →

Free forever tier includes 5 Verdict lookups a day. Plus €19/mo unlocks everything above. Cancel any time.

STOCKY VERDICT
49
/ 100 · Neutral

Or jump straight to the interactive dashboard for 2507.HK in the app.